BL2 |
blocking loop 2 |
COVID-19 |
coronavirus disease 2019 |
DUB |
deubiquitinating enzyme |
EF |
enrichment factor |
HBA |
hydrogen bond acceptor |
HBD |
hydrogen bond donor |
HCV |
hepatitis C virus |
HIV |
human immunodeficiency virus |
IC50
|
half maximal inhibitory concentration |
ISG |
interferon-stimulated gene |
ISG15 |
interferon-stimulated gene 15 |
LD50
|
lethal dose, 50% |
MERS-CoV |
Middle East respiratory syndrome coronavirus |
MLR |
multiple linear regression |
MM–GBSA |
molecular mechanics—generalized Born and surface area solvation |
Mpro |
main protease |
MW |
molecular weight |
PDB |
Protein Data Bank |
PLpro |
papain-like protease |
QSAR |
quantitative structure–activity relationship |
RMSD |
root-mean-square deviation |
SARS-CoV |
severe acute respiratory syndrome coronavirus |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
SP |
standard precision |
TEST |
Toxicity Estimation Software Tool |
TPSA |
topological polar surface area |
Ub |
ubiquitin |
Ubl |
ubiquitin-like (domain) |
UbVMe |
ubiquitin-vinyl methyl ester |
UCH-L1 |
ubiquitin carboxy-terminal hydrolase L1 |
UCH-L3 |
ubiquitin carboxy-terminal hydrolase L3 |
WHO |
World Health Organization |
XP |
extra precision |